Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
In This Article:
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales.
Terms and Privacy Policy